Skip to main content

Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Investor Securities Class Action Lawsuit 03/27/2025

  • If you purchased a significant amount of shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) between October 31, 2022, and August 2, 2024, and / or if you purchased any NYSE: ATNM shares prior to October 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: May 26, 2025. NYSE: ATNM investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 27, 2025 - An investor in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Actinium Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between October 31, 2022, and August 2, 2024.   New York base...



You must register (for free) or login to view the entire case.